The Biden administration yesterday announced the first 10 medicines that will be subject to price negotiations with Medicare, kicking off a landmark program that is expected to reduce the government’s drug spending but is being fought by the pharmaceutical industry in court. Via the New York Times: The medications on the list are taken by millions of older Americans and cost Medicare billions of dollars annually.